Inscripta

Recent Finacing

Series E

Recent Raise

$150M

Inscripta builds the Onyx benchtop digital genome engineering platform—integrated instrument, consumables, software, assays and MADzymes—to automate scalable, multiplexed, trackable CRISPR-based single-cell library creation and genotyping.

Founded 2015

Southern Finland, Finland

11-50

Private

inscripta.io

Highlights

Focus Areas

Internet

Machine Learning

Speech Recognition

Recent Investors

Financials

$350.5M

Total Raised

4

Funding rounds

15

Investors

Team

Upgrade to view the team

See the team members at Inscripta.